Evidence map›Paper›PMID 41526335›Full record

ArticleCell death & disease2026

Mutations in VPS18 lead to a neutrophil maturation defect associated with disturbed vesicle homeostasis.

Jincheng Gao, Almke Bader, Monika I Linder, Jingyuan Cheng, Mathis Richter, Raul da Costa, Annette Zehrer, Karl Mitt, Bastian Popper, Felix Meissner and 15 more

Abstract read
In one paragraph

Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Jincheng Gao *Institute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.ORCID http://orcid.org/0000-0002-5618-0755
Almke Bader *Institute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.ORCID http://orcid.org/0000-0003-2313-598X
Monika I LinderDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.
Jingyuan ChengMax-Planck Institute for Biochemistry, Planegg-Martinsried, Germany.
Mathis RichterInstitute of Experimental Pathology (ExPat), Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany.ORCID http://orcid.org/0000-0002-3110-6137
Raul da CostaInstitute of Experimental Pathology (ExPat), Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany.ORCID http://orcid.org/0000-0001-9666-8301
Annette ZehrerInstitute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.
Karl MittInstitute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.ORCID http://orcid.org/0009-0006-0965-9903
Bastian PopperCore Facility Animal Models, Biomedical Center, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.
Felix MeissnerMax-Planck Institute for Biochemistry, Planegg-Martinsried, Germany.ORCID http://orcid.org/0000-0003-1000-7989
Xiang WeiInstitute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.
Enrique de Vega GómezInstitute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.
Megumi TatematsuDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.
Meino RohlfsDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.
Stephanie Frenz-WiessnerDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.ORCID http://orcid.org/0000-0001-8862-3752
Mehmet KiziltugDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.
Ido SomekhPediatric Department A and the Immunology Service, Jeffrey Modell Foundation Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Joanne YacobovichDepartment of Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Orna Steinberg-ShemerDepartment of Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Petah Tikva, affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Raz SomechPediatric Department A and the Immunology Service, Jeffrey Modell Foundation Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Oliver SoehnleinInstitute of Experimental Pathology (ExPat), Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany.ORCID http://orcid.org/0000-0002-7854-0694
Bettina SchmidGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Christoph KleinDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.
Barbara WalzogInstitute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.ORCID http://orcid.org/0000-0001-7729-6565
Daniela Maier-BegandtInstitute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany. daniela.begandt@lrz.uni-muenchen.de.ORCID http://orcid.org/0000-0001-8491-9820

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) CRC914 (project A02)Deutsche Forschungsgemeinschaft (German Research Foundation) CRC914 (project A13)Deutsche Forschungsgemeinschaft (German Research Foundation) CRC914 (projects A02 and Z03)Deutsche Forschungsgemeinschaft (German Research Foundation) TRR332 (#449437943; project A02)Deutsche Forschungsgemeinschaft (German Research Foundation) TRR332 (#449437943; project B01)Deutsche Forschungsgemeinschaft (German Research Foundation) TRR332 (#449437943; project C03)
6 · The paper itself

Abstract

Neutrophils, the first cells to arrive at the site of inflammation, are rather short-lived cells and thus have to be constantly replenished. During neutrophil development, vesicle dynamics need to be fine-tuned and impaired vesicle trafficking has been linked to failure in neutrophil maturation. Here, we characterized the role of VPS18 as a central core component of CORVET & HOPS tethering complexes for neutrophil development. Using CRISPR/Cas9-engineered Hoxb8 cells with heterozygous mutations in Vps18, we found that VPS18 deficiency interfered with neutrophil development due to tethering complex instability. As a result, vesicle dynamics were impaired with a strong increase in LC3B-II and p62 levels, indicating autophagosome accumulation and reduced autophagic flux. With transmission electron microscopy, we verified the increase in autophagosomes and also found irregularly shaped vesicular structures in Vps18 mutants. Subsequently, Vps18 mutant neutrophil progenitors underwent premature apoptosis. We described a novel patient with a heterozygous stop-gain mutation in VPS18 suffering from neutropenia and recurrent infections. To verify our findings in the human system, we used human induced pluripotent stem cells (iPSCs). Upon differentiation into neutrophils, loss of VPS18 resulted in an almost complete absence of iPSC-derived developing neutrophils. Heterozygous VPS18 mutant and patient mutation-harboring iPSCs were characterized by strongly reduced numbers of developing neutrophils. Zebrafish larvae with heterozygous mutations in vps18 were also characterized by significantly reduced neutrophil numbers. This study shows the pivotal impact of VPS18 for adequate vesicle dynamics during neutrophil development which might be relevant in the context of vesicle trafficking during granulopoiesis and congenital neutropenia.

Indexed as

HomeostasisMutationNeutrophilsVesicular Transport ProteinsAnimalsAutophagosomesAutophagyCell DifferentiationHumansNeutropeniaZebrafishVesicular Transport Proteins

Identifiers

PMID41526335
PMCPMC12876832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.